The a2 Milk Co Ltd (ASX: A2M) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
The a2 Milk Co Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
The a2 Milk Co Ltd (ASX: A2M)
Latest News
⏸️ Investing
Why these 4 ASX shares are deep in the red today
⏸️ Investing
Why a2 Milk Company Ltd (Australia) shares sank 8% lower today
⏸️ Investing
Are these the secrets behind Australia's best ASX investors?
⏸️ Investing
Why October has been a huge month for the ASX
⏸️ Investing
ALL ORDINARIES finishes lower Friday: 9 shares you missed
⏸️ Investing
It has been another big week for the Aussie stock market
⏸️ Investing
Who else wants to be a stock market millionaire?
⏸️ Investing
a2 Milk Company Ltd (Australia) shares just hit an all-time high
⏸️ Investing
ALL ORDINARIES finishes lower Monday: 8 shares you missed
⏸️ Investing
The Bellamy's Australia Ltd share price has almost doubled in three months
⏸️ Investing
Here's why I own shares in a2 Milk Company Ltd (Australia)
⏸️ Investing
Why Wattle Health Australia Ltd shares are up 160% in three months
Frequently Asked Questions
-
The a2 Milk Company Ltd does not currently pay a dividend.
-
The a2 Milk Company Ltd does not currently have a dividend reinvestment program.
-
The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.
A2M ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About The a2 Milk Co Ltd
A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.
The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.
The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.
A2M Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
06 Sep 2024 | $5.56 | $0.03 | 0.54% | 1,290,529 | $5.50 | $5.61 | $5.49 |
05 Sep 2024 | $5.53 | $-0.03 | -0.54% | 1,082,652 | $5.55 | $5.57 | $5.49 |
04 Sep 2024 | $5.56 | $0.03 | 0.54% | 1,574,729 | $5.47 | $5.60 | $5.43 |
03 Sep 2024 | $5.53 | $-0.20 | -3.49% | 1,911,740 | $5.74 | $5.76 | $5.53 |
02 Sep 2024 | $5.73 | $0.14 | 2.50% | 2,904,215 | $5.50 | $5.79 | $5.49 |
30 Aug 2024 | $5.59 | $-0.06 | -1.06% | 2,884,418 | $5.67 | $5.68 | $5.58 |
29 Aug 2024 | $5.65 | $-0.06 | -1.05% | 1,451,979 | $5.69 | $5.72 | $5.62 |
28 Aug 2024 | $5.71 | $0.00 | 0.00% | 1,390,670 | $5.70 | $5.74 | $5.67 |
27 Aug 2024 | $5.71 | $-0.15 | -2.56% | 1,985,212 | $5.80 | $5.84 | $5.63 |
26 Aug 2024 | $5.86 | $0.09 | 1.56% | 1,123,926 | $5.80 | $5.90 | $5.80 |
23 Aug 2024 | $5.77 | $-0.13 | -2.20% | 1,456,212 | $5.87 | $5.91 | $5.77 |
22 Aug 2024 | $5.90 | $0.25 | 4.42% | 3,064,410 | $5.73 | $5.91 | $5.66 |
21 Aug 2024 | $5.65 | $-0.09 | -1.57% | 3,424,154 | $5.82 | $5.85 | $5.60 |
20 Aug 2024 | $5.74 | $0.04 | 0.70% | 6,717,903 | $5.71 | $5.74 | $5.55 |
19 Aug 2024 | $5.70 | $-1.31 | -18.69% | 16,281,198 | $5.86 | $5.93 | $5.34 |
16 Aug 2024 | $7.01 | $0.29 | 4.32% | 3,754,960 | $6.83 | $7.12 | $6.81 |
15 Aug 2024 | $6.72 | $0.00 | 0.00% | 1,883,457 | $6.70 | $6.79 | $6.66 |
14 Aug 2024 | $6.72 | $-0.02 | -0.30% | 2,142,943 | $6.81 | $6.89 | $6.68 |
13 Aug 2024 | $6.74 | $-0.06 | -0.88% | 1,203,033 | $6.79 | $6.81 | $6.68 |
12 Aug 2024 | $6.80 | $0.03 | 0.44% | 789,579 | $6.84 | $6.86 | $6.74 |
09 Aug 2024 | $6.77 | $0.19 | 2.89% | 1,334,257 | $6.64 | $6.80 | $6.62 |
08 Aug 2024 | $6.58 | $-0.06 | -0.90% | 1,650,696 | $6.58 | $6.61 | $6.53 |
07 Aug 2024 | $6.64 | $-0.03 | -0.45% | 2,482,218 | $6.64 | $6.70 | $6.54 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
30 Aug 2024 | David Bortolussi | Buy | 490,906 | $2,744,164 |
Conversion of securities.
|
30 Aug 2024 | David Bortolussi | Exercise | 490,906 | $2,744,164 |
Conversion of securities. 1,191,246 performance rights
|
15 Dec 2023 | David Bortolussi | Issued | 690,066 | $2,794,767 |
Issue of securities. 1,682,152 performance rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Warwick Lynton Every-Burns | Non-Executive Director | Aug 2016 |
Mr Every-Burns has been a career Consumer Packaged Goods (CPG) executive of global scale. His executive roles have included a career with The Clorox Company of the USA as Senior Vice President, International, based in the USA and prior to that as VP Asia Pacific. His earlier roles included Managing Director of NationalPak Limited (the Glad Products Company ultimately acquired by Clorox) and a long career with Unilever plc where he was based in Australia. He is also Chair of the People and Remuneration Committee.
|
Mr David Landt Bortolussi | Chief Executive OfficerManaging Director | Feb 2021 |
Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
|
Ms Philippa (Pip) Mary Greenwood | Non-Executive Director | Jul 2019 |
Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
|
Ms Kathryn(Kate) Mitchell | Non-Executive Director | Jun 2023 |
Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
|
Ms Sandra Yu | Non-Executive Director | Mar 2022 |
Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
|
Mr David Wang | Non-Executive Director | Sep 2022 |
Mr Wang brings expertise across the Asia-Pacific region in manufacturing and supply chain with over 30 years of experience in industrial and consumer goods businesses including 15 years in senior executive leadership roles in China and international. In his career, David has held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology, sales and marketing throughout Asia. David sits on both the Risk Management and the People and Remuneration Committees.
|
Mr Jaron McVicar | Company SecretaryGeneral Counsel | Nov 2016 |
-
|
Jaron McVicar | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 113,290,528 | 15.67% |
Citicorp Nominees Pty Limited | 96,163,814 | 13.30% |
BNP Paribas Nominees NZ Limited Bpss40* | 42,529,528 | 5.88% |
J P Morgan Nominees Australia Pty Limited | 34,661,044 | 4.79% |
HSBC Nominees (New Zealand) Limited* | 26,156,306 | 3.62% |
Tea Custodians Limited* | 21,013,734 | 2.91% |
HSBC Custody Nominees (Australia) Limited Gsco Eca | 20,980,543 | 2.90% |
Accident Compensation Corporation* | 20,509,205 | 2.84% |
JPMORGAN Chase Bank* | 18,595,095 | 2.57% |
New Zealand Superannuation Fund Nominees Limited* | 17,659,815 | 2.44% |
Citibank Nominees (NZ) Ltd* | 15,787,511 | 2.18% |
New Zealand Depository Nominee | 14,021,429 | 1.94% |
National Nominees Limited | 13,425,469 | 1.86% |
HSBC Nominees (New Zealand) Limited* i | 9,463,432 | 1.31% |
Premier Nominees Limited* | 8,473,699 | 1.17% |
Public Trust* | 7,323,398 | 1.01% |
UBS Nominees Pty Ltd | 6,938,917 | 0.96% |
New Zealand Permanent Trustees Limited* | 6,325,699 | 0.88% |
BNP Paribas Noms Pty Ltd | 6,123,304 | 0.85% |
JBWere (NZ) Nominees Limited | 5,945,531 | 0.82% |